Summary
168.34 -3.62(-2.11%)11/15/2024
ICU Medical, Inc. (ICUI)
ICUI reported last earnings on 2024-11-12 after the market. An EPS of $1.59 was observed compared to an estimated EPS of $1.25, resulting in a surprise value of $0.34. A revenue of $589 million was observed compared to an estimated revenue of $575 million, resulting in a surprise value of $14 Million.
ICU Medical, Inc. (ICUI)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| -2.11 | -4.78 | -6.28 | 6.41 | 60.94 | 90.24 | -3.50 | 3,550.75 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
Earnings
Fundamental Ratings
| Category | Rating |
| Main Rating | C |
| Recommended Rating | Sell |
| DCF | Buy |
| ROE | Strong Sell |
| ROA | Strong Sell |
| Debt/Equity | Strong Sell |
| P/E | Strong Sell |
| P/B | Neutral |
| Trading Data | ||
| Close | 168.34 | |
| Open | 172.67 | |
| High | 172.67 | |
| Low | 166.66 | |
| Volume | 154,873 | |
| Change | -3.62 | |
| Change % | -2.11 | |
| Avg Volume (20 Days) | 213,236 | |
| Volume/Avg Volume (20 Days) Ratio | 0.73 | |
| 52 Week Range | 82.82 - 196.26 | |
| Price vs 52 Week High | -14.23% | |
| Price vs 52 Week Low | 103.26% | |
| Range | -2.51 | |
| Gap Up/Down | -2.21 | |
Fundamentals | ||
| Market Capitalization (Mln) | 4,318 | |
| EBIDTA | 262,428,992 | |
| PE Ratio | 0.0000 | |
| PEG Ratio | 0.9911 | |
| WallStreet Target Price | 136.00 | |
| Book Value | 84.8690 | |
| Earnings Per Share | -2.4500 | |
| EPS Estimate Current Quarter | 0.8200 | |
| EPS Estimate Next Quarter | 1.0000 | |
| EPS Estimate Current Year | 4.8300 | |
| EPS Estimate Next Year | 6.5600 | |
| Diluted EPS (TTM) | -2.4500 | |
| Revenues | ||
| Profit Marging | -0.0263 | |
| Operating Marging (TTM) | 0.0101 | |
| Return on asset (TTM) | 0.0048 | |
| Return on equity (TTM) | -0.0285 | |
| Revenue TTM | 2,257,132,032 | |
| Revenue per share TTM | 93.4900 | |
| Quarterly Revenue Growth (YOY) | -0.0040 | |
| Quarterly Earnings Growth (YOY) | -0.2380 | |
| Gross Profit (TTM) | 697,761,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 0.0000 | |
| Forward PE | 20.7039 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 1.1279 | |
| Revenue Enterprise Value | 1.7016 | |
| EBITDA Enterprise Value | 15.1824 | |
| Shares | ||
| Shares Outstanding | 24,366,000 | |
| Shares Float | 21,207,670 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.08 | |
| Insider (%) | 12.86 | |
| Institutions (%) | 90.65 | |
11/12 20:45 EST - seekingalpha.com
ICU Medical Inc. (ICUI) Q3 2024 Earnings Call Transcript
ICU Medical Inc. (NASDAQ:ICUI ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants John Mills - ICR Vivek Jain - Chief Executive Officer and Chairman Brian Bonnell - Chief Financial Officer Conference Call Participants Brett Fishbin - KeyBanc Eric Fleming - Raymond...
ICU Medical Inc. (ICUI) Q3 2024 Earnings Call Transcript
ICU Medical Inc. (NASDAQ:ICUI ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants John Mills - ICR Vivek Jain - Chief Executive Officer and Chairman Brian Bonnell - Chief Financial Officer Conference Call Participants Brett Fishbin - KeyBanc Eric Fleming - Raymond...
11/12 18:51 EST - zacks.com
ICU Medical (ICUI) Tops Q3 Earnings and Revenue Estimates
ICU Medical (ICUI) came out with quarterly earnings of $1.59 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $1.57 per share a year ago.
ICU Medical (ICUI) Tops Q3 Earnings and Revenue Estimates
ICU Medical (ICUI) came out with quarterly earnings of $1.59 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $1.57 per share a year ago.
11/12 16:05 EST - prnewswire.com
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc., a Subsidiary of Otsuka Holdings Co. Ltd., Announce Creation of a Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America
The partnership creates one of the largest global IV solutions manufacturing networks with combined production of an estimated 1.4 billion annual units and aims to bring additional supply chain resiliency and new innovation to the North American IV solutions market. Joint venture becomes part of a...
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc., a Subsidiary of Otsuka Holdings Co. Ltd., Announce Creation of a Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America
The partnership creates one of the largest global IV solutions manufacturing networks with combined production of an estimated 1.4 billion annual units and aims to bring additional supply chain resiliency and new innovation to the North American IV solutions market. Joint venture becomes part of a...
11/06 08:30 EST - globenewswire.com
ICU Medical to Participate at the UBS Global Healthcare Conference
SAN CLEMENTE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the UBS Global Healthcare Conference being held in Rancho Palos Verdes,...
ICU Medical to Participate at the UBS Global Healthcare Conference
SAN CLEMENTE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the UBS Global Healthcare Conference being held in Rancho Palos Verdes,...
10/28 11:05 EST - zacks.com
ICU Medical (ICUI) Expected to Beat Earnings Estimates: Should You Buy?
ICU Medical (ICUI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ICU Medical (ICUI) Expected to Beat Earnings Estimates: Should You Buy?
ICU Medical (ICUI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
10/28 08:30 EST - globenewswire.com
ICU Medical Announces Time of Third Quarter 2024 Earnings Conference Call
SAN CLEMENTE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2024 earnings release and conference call.
ICU Medical Announces Time of Third Quarter 2024 Earnings Conference Call
SAN CLEMENTE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2024 earnings release and conference call.
10/18 13:16 EST - zacks.com
Will ICU Medical (ICUI) Beat Estimates Again in Its Next Earnings Report?
ICU Medical (ICUI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will ICU Medical (ICUI) Beat Estimates Again in Its Next Earnings Report?
ICU Medical (ICUI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
09/25 11:45 EST - zacks.com
ICU Medical's Stock Rises Despite Bivona Tracheostomy Tube Recall
ICUI's Smiths Medical recalls Bivona tracheostomy tubes over a defect that may lead to serious health risks, including airway loss and death.
ICU Medical's Stock Rises Despite Bivona Tracheostomy Tube Recall
ICUI's Smiths Medical recalls Bivona tracheostomy tubes over a defect that may lead to serious health risks, including airway loss and death.
09/17 10:20 EST - zacks.com
ICU Medical, Inc. (ICUI) Hits Fresh High: Is There Still Room to Run?
ICU Medical (ICUI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
ICU Medical, Inc. (ICUI) Hits Fresh High: Is There Still Room to Run?
ICU Medical (ICUI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
08/22 10:46 EST - zacks.com
Is ICU Medical (ICUI) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is ICU Medical (ICUI) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
08/21 08:30 EST - globenewswire.com
ICU Medical to Participate in Upcoming Investor Conferences
SAN CLEMENTE, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences in September:
ICU Medical to Participate in Upcoming Investor Conferences
SAN CLEMENTE, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences in September:
08/07 20:00 EST - seekingalpha.com
ICU Medical Inc (ICUI) Q2 2024 Earnings Call Transcript
ICU Medical Inc (NASDAQ:ICUI ) Q2 2024 Results Conference Call August 7, 2024 4:30 PM ET Company Participants John Mills - Managing Partner Vivek Jain - CEO & Chairman of the Board Brian Bonnell - CFO & Treasurer Conference Call Participants Larry Solow - CJS Securities Kristen Stewart - CL King...
ICU Medical Inc (ICUI) Q2 2024 Earnings Call Transcript
ICU Medical Inc (NASDAQ:ICUI ) Q2 2024 Results Conference Call August 7, 2024 4:30 PM ET Company Participants John Mills - Managing Partner Vivek Jain - CEO & Chairman of the Board Brian Bonnell - CFO & Treasurer Conference Call Participants Larry Solow - CJS Securities Kristen Stewart - CL King...
08/07 19:15 EST - zacks.com
ICU Medical (ICUI) Surpasses Q2 Earnings and Revenue Estimates
ICU Medical (ICUI) came out with quarterly earnings of $1.56 per share, beating the Zacks Consensus Estimate of $0.98 per share. This compares to earnings of $1.88 per share a year ago.
ICU Medical (ICUI) Surpasses Q2 Earnings and Revenue Estimates
ICU Medical (ICUI) came out with quarterly earnings of $1.56 per share, beating the Zacks Consensus Estimate of $0.98 per share. This compares to earnings of $1.88 per share a year ago.
05/20 04:42 EST - https://www.defenseworld.net
Swiss National Bank Lowers Stock Position in ICU Medical, Inc. (NASDAQ:ICUI)
Swiss National Bank decreased its holdings in ICU Medical, Inc. (NASDAQ:ICUI – Free Report) by 10.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 40,419 shares of the medical instruments...
Swiss National Bank Lowers Stock Position in ICU Medical, Inc. (NASDAQ:ICUI)
Swiss National Bank decreased its holdings in ICU Medical, Inc. (NASDAQ:ICUI – Free Report) by 10.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 40,419 shares of the medical instruments...
05/07 22:43 EST - seekingalpha.com
ICU Medical, Inc. (ICUI) Q1 2024 Earnings Call Transcript
ICU Medical, Inc. (NASDAQ:ICUI ) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants John Mills - Managing Partner at ICR Vivek Jain - Chief Executive Officer & Chairman Brian Bonnell - Chief Financial Officer Conference Call Participants Jayson Bedford - Raymond James...
ICU Medical, Inc. (ICUI) Q1 2024 Earnings Call Transcript
ICU Medical, Inc. (NASDAQ:ICUI ) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants John Mills - Managing Partner at ICR Vivek Jain - Chief Executive Officer & Chairman Brian Bonnell - Chief Financial Officer Conference Call Participants Jayson Bedford - Raymond James...
05/07 18:56 EST - zacks.com
ICU Medical (ICUI) Q1 Earnings and Revenues Surpass Estimates
ICU Medical (ICUI) came out with quarterly earnings of $0.96 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $1.74 per share a year ago.
ICU Medical (ICUI) Q1 Earnings and Revenues Surpass Estimates
ICU Medical (ICUI) came out with quarterly earnings of $0.96 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $1.74 per share a year ago.
05/07 16:05 EST - globenewswire.com
ICU Medical Announces First Quarter 2024 Results
SAN CLEMENTE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2024.
ICU Medical Announces First Quarter 2024 Results
SAN CLEMENTE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2024.
04/23 08:30 EST - globenewswire.com
ICU Medical Announces Time of First Quarter 2024 Earnings Conference Call
SAN CLEMENTE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2024 earnings release and conference call.
ICU Medical Announces Time of First Quarter 2024 Earnings Conference Call
SAN CLEMENTE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2024 earnings release and conference call.
03/13 08:30 EST - globenewswire.com
ICU Medical to Present at the KeyBanc Life Sciences & MedTech Investor Forum
SAN CLEMENTE, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the KeyBanc Life Sciences & MedTech Investor Forum being held virtually March...
ICU Medical to Present at the KeyBanc Life Sciences & MedTech Investor Forum
SAN CLEMENTE, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the KeyBanc Life Sciences & MedTech Investor Forum being held virtually March...